Combining new MRI methods - MR spectroscopy, functional MRI, diffusion tensor imaging

Imaging Decisions MRI

Volumn 9, Issue 1, 2005, Pages 39-48

  Sijens, Paul E ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Activation; Diffusion; Diffusion tensor imaging; Functional MRI; Magnetic resonance spectroscopy; Metabolism

Indexed keywords

CHOLINE; DEOXYHEMOGLOBIN; GLUCOSE; LACTIC ACID; N ACETYLASPARTIC ACID; OXYHEMOGLOBIN;

AEROBIC METABOLISM; ANISOTROPY; BLOOD OXYGENATION; BRAIN METABOLISM; DIFFUSION TENSOR IMAGING; ENERGY METABOLISM; EPILEPSY; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OPTIC CHIASM; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SEIZURE; SHORT SURVEY; VISUAL CORTEX; VISUAL STIMULATION;

EID: 18444368091     PISSN: 14333317     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1617-0830.2005.00039.x     Document Type: Short Survey

References (48)

1. Heider F, Kida I, Behar KL, et al. Quantitative functional imaging of the brain; towards mapping neuronal activity by BOLD fMRI. NMR Biomed 2001; 14: 413-431.
2. Shulman RG, Rothman DL. Interpreting functional imaging studies in terms of neurotransmitter cycling. Proc Natl Acad Sci USA 1998; 95: 11993-11998.
3. Rothman DL, Sibson NR, Hyder F, Shen J, Behar KL, Shulman RG. In vivo nuclear magnetic resonance studies of the relationship between the glutamate-glutamine neurotransmitter cycle and functional neuroenergetics. Phil Trans R Soc Lond B 1999; 354: 1165-1177.
4. 13C} MRS and fMRI. Magn Reson Med 2001; 45: 349-355.
5. 1MRS and functional MRI during and after prolonged nonconvulsive seizure activity. Neurology 2000; 55; 1677-1682.
6. Magistretti PJ, Pellerin L, Rothman DL, Shulman RG. Energy on demand. Science 1999; 283: 496-497.
7. 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci USA 1991; 88: 5829-5831.
8. 31P magnetic resonance spectroscopy. J Cereb Blood Flow Metab 1992; 12: 584-592.
9. 1H MRS study. Neurology 1994; 44: 557-559.
10. Frahm J, Krüger G, Merboldt KD, Hänicke W, Kleinschmidt A. Dynamic uncoupling and recoupling of perfusion and oxidative metabolism during focal brain activation. Magn Reson Med 1996; 35: 143-148.
11. Merboldt K-D, Bruhn H, Haenicke W, Michaelis T, Frahm J. Decrease of glucose in the human visual cortex during photic stimulation. Magn Reson Med 1992; 25: 187-194.
12. Etta A, Fischer-Klein C, Chemelli A, Daxer A, Felber S. Nuclear magnetic resonance spectroscopy. Principles and applications in neuro-opthalmology. Int Opthalmol 1994; 18: 171-181.
13. Mangia S, Garreffa G, Bianciardi M, Giove F, Di Salle F, Maraviglia B. The aerobic brain: lactate decrease at the onset of neural activity. Neuroscience 1993; 118: 7-10.
14. 1H MR spectroscopy and fMRI of the visual pathways. Eur Radiol 2005; 15: 47-52.
15. 1H Chemical shift imaging reveals loss of brain tumor choline signal after administration of Gd-contrast agent. Magn Reson Med 1997; 37: 222-225.
16. Wandell BA. Computational neuroimaging of human visual cortex. Annu Rev Neurosci 1999; 22: 145-173.
17. Brown AM, Tekkok SB, Ransom BR. Glycogen regulation and functional role in mouse white matter. J Physiol 2003; 549: 501-512.
18. Wender R, Brown AM, Fern R, Swanson RA, Farrell K, Ransom BR. Astrocytic glycogen influences axon function and survival during glucose deprivation in central white matter. J Neurosci 2000; 20: 6804-6810.
19. 1H Chemical shift imaging characterization of human brain tumor and edema. Eur Radiol 2002; 12: 2056-2061.
20. Sijens PE, den Heijer T, de Leeuw FE, et al. MR Spectroscopy detection of lactate and lipid signals in the brains of healthy elderly people. Eur Radiol 2001; 11: 1495-1501.
21. 1H-MRS study. Brain Res 1995; 670: 326-328.
22. Richards TL, Corina D, Serafini S, et al. Effects of a phonologically driven treatment for dyslexia on lactate levels measured by proton MR spectroscopic imaging. AJNR Am J Neuroradiol 2000; 21:916-922.
23. Richards TL, Gates GA, Gardner JC, et al. Functional MR spectroscopy of the auditory cortex in healthy subjects and patients with sudden hearing loss. AJNR Am J Neuroradiol 1997; 18: 611-620.
24. Urrila AS, Hakkarainen A, Heikkinen S, et al. Metabolic imaging of human cognition: an fMRI/1H-MRS study of brain lactate response to silent word generation. J Cereb Blood Flow Metab 2003; 23: 942-948.
25. Black JA, Waxman SG. The perinodal astrocyte. Glia 1988; 1: 169-183.
26. Magistretti PJ. Cellular bases of functional brain imaging: insights from neuron-glia metabolic imaging. Brain Res 2000; 886: 108-112.
27. 1H magnetic resonance spectroscopy of the internal capsule in human brain: a feasibility study to detect lactate following contralateral motor activity. Eur Radiol 2005 (in press).
28. 1H magnetic resonance spectroscopy in human hydrocephalus. J Magn Reson Imaging 2003; 17: 291-299.
29. 1H MRS and DWI in evaluation of temporal lobe epilepsy. Neurology 2000; 58: 1745-1753.
30. Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopy and diffusion tensor brain MR imaging in X-linked adeboleukodystrophy: initial experience. Radiology 2002; 246: 245-252.
31. Rumpel H, Khoo JB, Chang HM, et al. Correlation of the apparent diffusion constant and the creatine level in early ischaemic stroke: a comparison of different ischaemic patterns by magnetic resonance.
32. Brockman K, Finsterbusch J, Schara U, Wilichowski E, Frahm J, Hanefeld F. Stroke-like pattren in DTI and MRS of childhood mitochondrial leukoencephalopathy. Neuroradiology 2004; 46: 267-271.
33. Rock JP, Scarpace L, Hearshen D, et al. Associations among magnetic resonance spectroscopy, apparent diffusion coefficients and image guided histopathology with special attention to radiation necrosis. Neurosurgery 2004; 54: 1111-1117.
34. Mori S, van Zijl PCM. Fibre tracking: principles and strategies - a technical review. NMR Biomed 2002; 15: 468-480.
35. Eichler FS, Itoh R, Barker PB, et al. Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 202; 225: 245-252.
36. Clark C, Weiring D, Miller D. Diffusion imaging of the spinal cord in vivo: estimation of the principal diffusion and application to multiple sclerosis. Magn Reson Med 2000; 43: 133-138.
37. De Stefano N, Iannucci G, Sormani MP, et al. MR correlates of cerebral atrophy in patients with multiple sclerosis. J Neurol 2002; 249: 1072-1077.
38. Ciccarelli O, Werring DJ, Barker GJ, et al. A study of the mechanisms of normal-appearing white matter damage in multiple sclerosis using diffusion tensor imaging-evidence of Wallerian degeneration. J Neurol 2003; 250: 287-292.
39. Oh J, Henry RG, Genain C, Nelson SJ, Pelletier D. Mechanisms of normal appearing injury related to pericallosal T1 lesions in multiple sclerosis using directional diffusion tensor and H-1 MRS imaging. J Neurol Neurosurg Psych 2004; 75: 1281-1286.
40. Irwan R, Sijens PE, Kappert P, Oudkerk M. Phase correction for eight-channel head coil in MR spectroscopy. In: Proceedings ISMRM Twelfth Scientific Meeting and Exhibition, 2004. International Society of Magnetic Resonance in Medicine, p. 1802.
41. Degaonkar MN, Khubchandhani M, Dhawan JK, Jayasundar R, Jagannathan NR. Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC) - induced experimental demyelinating lesion model. NMR Biomed 2002; 15: 293-300.
42. Tartaglia MC, Narayanan S, De Stefano N, et al. Choline is increased in pre-lesional normal appearing white matter in multiple sclerosis. J Neurol 2002; 249: 1382-1390.
43. Michaelis T, Merboldt K-D, Bruhn H, Hänecke W, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: quantification of localized proton MR spectra. Radiology 1993; 187: 219-227.
44. Guo AC, Macfall JR, Provenzale JM. Multiple sclerosis: diffusion tensor imaging for evaluation of normal-appearing white matter. Radiology 2002; 222: 729-736.
45. Coombs BD, Best A, Brown MS, et al. Multiple sclerosis pathology in the normal appearing and abnormal white matter of the corpus callosum by diffusion tensor imaging. Mult Scler 2004; 10: 392-397.
46. 1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J Neurol 1999; 246: 1023-1026.
47. 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler 2000; 6: 148-155.
48. Narayana PA, Wolinsky JS, Rao SB, He R, Mehta M., PROMiSe Trial MRSI Group. Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis. Mult Scler 2004; 10(Suppl. 1): S73-S78.